Zevra Therapeutics (NASDAQ: ZVRA): Assessing Financial Efficiency in Rare Disease Biopharma
| Show full article |
|
This functionality is available for registred users only
|
-
Full nameZevra Therapeutics Inc
-
Registration countryUSA
-
IndustryPharmaceutical Preparation and Biotechnology
-
М/S&P/F
*** /*** /***









